Stay updated on TGRX-326 Chinese Phase I Clinical Trial
Sign up to get notified when there's something new on the TGRX-326 Chinese Phase I Clinical Trial page.

Latest updates to the TGRX-326 Chinese Phase I Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedSponsor entity updated from Shenzhen TargetRx, Inc. to Shenzhen TargetRx Co., Ltd.SummaryDifference0.2%

- Check19 days agoChange DetectedContacts/Locations and Sponsor/Collaborators sections were added; the record history shows revision to v3.5.0 (replacing v3.4.3).SummaryDifference0.3%

- Check26 days agoChange DetectedAdded Revision: v3.4.3; removed Revision: v3.4.2 from the Record History.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded Revision: v3.4.2 to the study record history. Removed the funding-lapse notice and Revision: v3.4.1.SummaryDifference0.9%

- Check61 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH Clinical Center operations was added, and the record shows a Revision: v3.4.1 replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check69 days agoChange DetectedUI and diff-display updates (Show glossary toggle, color-coded highlights, and Revision: v3.4.0) with deletions of No FEAR Act data; these do not affect core study details or statuses. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

Stay in the know with updates to TGRX-326 Chinese Phase I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TGRX-326 Chinese Phase I Clinical Trial page.